trending Market Intelligence /marketintelligence/en/news-insights/trending/bsbIQxReHkIanJ_7UMzQEg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Alliance Pharma adds 2 directors


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Alliance Pharma adds 2 directors

Alliance Pharma PLC has appointed Jo Le Couilliard and Richard Jones as nonexecutive directors to the board, effective Jan. 1, 2019.

Le Couilliard has served as a nonexecutive director of Circassia Pharmaceuticals PLC since Feb. 13. She was also senior vice president, global commercial transformation at GlaxoSmithKline PLC. In addition, she served as a nonexecutive director of the Frimley Park Hospital NHS Foundation Trust.

Jones is CFO of Mereo BioPharma Group PLC, a clinical-stage biopharmaceutical company. Previously, he was CFO of Shield Therapeutics PLC, a specialty pharmaceutical company.

Chippenham, U.K.-based Alliance Pharma operates as a specialty pharmaceutical company.